Short-course, direct-acting antivirals and ezetimibe to prevent HCV infection in recipients of organs from HCV-infected donors: a phase 3, single-centre, open-label study

Authors: Jordan J Feld, Marcelo Cypel, Deepali Kumar, Harel Dahari, Rafaela Vanin Pinto Ribeiro, Nikki Marks, Nellie Kamkar, Ilona Bahinskaya, Fernanda Q Onofrio, Mohamed A Zahoor, Orlando Cerrochi, Kathryn Tinckam, S Joseph Kim, Jeffrey Schiff, Trevor W Reichman, Michael McDonald, Carolina Alba, Thomas K Waddell, Gonzalo Sapisochin, Markus Selzner, Shaf Keshavjee, Harry L A Janssen, Bettina E Hansen, Lianne G Singer, Atul Humar

Published: 2020-05-06

DOI: 10.1016/s2468-1253(20)30081-9

Source: Full article

---

Abstract

No abstract found.